Nov 9 (Reuters) - Immutep Ltd (IMM) :
- IMMUTEP REPORTS IMPROVED AND STATISTICALLY SIGNIFICANT SURVIVAL BENEFIT FOR THREE KEY PATIENT GROUPS IN FINAL PHASE IIB AIPAC STUDY RESULTS IN METASTATIC BREAST CANCER
- Forums
- ASX - By Stock
- News: IMM Immutep Reports Phase IIb Final AIPAC Study Results
Nov 9 (Reuters) - Immutep Ltd (IMM) : IMMUTEP REPORTS IMPROVED...
-
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
28.0¢ |
Change
-0.005(1.75%) |
Mkt cap ! $406.7M |
Open | High | Low | Value | Volume |
29.0¢ | 29.0¢ | 27.5¢ | $1.341M | 4.777M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 177846 | 28.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.5¢ | 897934 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 37096 | 0.310 |
7 | 58283 | 0.300 |
1 | 24147 | 0.295 |
9 | 178304 | 0.280 |
7 | 274393 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.265 | 55960 | 2 |
0.275 | 2730 | 4 |
0.285 | 274814 | 4 |
0.290 | 203455 | 6 |
0.295 | 242762 | 7 |
Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |